Evidence map›Paper›PMID 41048315›Full record

ArticleInternational journal of women's health2025

Clinical Prognostic Factors for Overall Survival in Patients Undergoing Radical Radiotherapy for Cervical Cancer.

Fangfang Hao, Nanfeng Xiao, Meng Wang, Houyi Sang, Judong Luo, Jing Song

Abstract read
In one paragraph

Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fangfang Hao *Department of Obstetrics and Gynecology, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.ORCID 0009-0004-8085-2875
Nanfeng Xiao *Department of Obstetrics and Gynecology, Jiangnan University, Wuxi, Jiangsu, People's Republic of China.
Meng Wang *Department of Radiotherapy, Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Houyi SangDepartment of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, People's Republic of China.
Judong LuoDepartment of Radiotherapy, Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Jing SongDepartment of Obstetrics and Gynecology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Cervical carcinoma (CC) represents the predominant malignancy affecting the female population, with patient outcomes being a critical focus of clinical investigation. This research conducts a comprehensive evaluation of the clinical determinants influencing short-term survival rates in CC patients receiving definitive radiotherapy treatment. Methods: A total of 99 cervical cancer patients who received radical radiotherapy between April 2017 and March 2022 at two medical institutions were retrospectively examined. Clinical outcomes were evaluated using the Kaplan-Meier method and the Cox proportional hazards model. Results: A total of ninety - nine patients with cervical cancer who received radical radiotherapy were included in the study. The overall survival (OS) rate at 2 - year follow - up was 77.8%.COX unifactorial and multifactorial showed that the analysis of prognostic-related factors suggested that the higher the history of miscarriage and FIGO stage, the lower 2-year OS, and that the history of miscarriage and FIGO stage were independent factors affecting the short-term overall survival, and the difference of all of them was statistically significant (P < 0.05). Conclusion: A history of miscarriage and the FIGO classification stage serve as independent predictors of overall survival (OS) during the initial 24-month period for cervical carcinoma patients undergoing definitive radiotherapy. This study conducted a comprehensive analysis of short-term prognostic indicators for cervical squamous cell carcinoma patients undergoing radical chemoradiotherapy.

Indexed as

cervical canceroverall survivalprognosticradical radiotherapy

Identifiers

PMID41048315
PMCPMC12493931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.